Brookmont Capital Management Baxter International Inc Transaction History

Brookmont Capital Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 28, 2020	SELL	$71.57 - $93.3 $238,614 - $311,062	-3,334 Closed	0 $0
Q4 2019 Jan 22, 2020	SELL	$76.7 - $88.45 $59,135 - $68,194	-771 Reduced 18.78%	3,334 $279,000
Q3 2019 Nov 07, 2019	BUY	$81.4 - $89.78 $4,639 - $5,117	57 Added 1.41%	4,105 $359,000
Q4 2018 Feb 12, 2019	BUY	$61.45 - $77.8 $8,971 - $11,358	146 Added 3.74%	4,048 $266,000
Q3 2018 Nov 08, 2018	BUY	$70.71 - $77.75 $275,910 - $303,380	3,902 New	3,902 $301,000

1,007

450M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.7B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Brookmont Capital Management, based on Form 13F filings with the SEC.

Stay updated on Brookmont Capital Management with notifications on news.